PMVP · PMV Pharmaceuticals Inc
United States · RS rating 63 · As of 2026-11-03
| Price | 1.38 USD |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 19 / 88 / 49 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 24 / 38 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +23.3% |
| Market cap (USD) | $76.3M |